Table 1.

Clinical features of non-probiotic group.

Moderate (M) and severe(S) pneumonia	Steroid and LWMAH	Hospitalization period (Day)	Specific treatment (Sp) (anti-IL-1,Anti-IL-6,Plazma)	Sp treatment type	Sp. Treatment type	Sp.treatment type	Antibiotic	Antibiotic type	Antibiotic type	Dead	Thorax CT resolution 6 day of hospitalization	Thorax CT resolution on 3 weeks	Hospitalization IL-6 levels (pg/ml)	3 weeks ıl-6 level
M	Yes	14	No				No			No	No	No	80	50
M	Yes	13	No				No			No	No	No	58	N/A
M	Yes	11	No				No			No	Yes	Yes	36	15
S	Yes	12	Yes	Tocilizumab			Yes	Ceftriaxone		No	No	N/A	77	36
M	Yes	14	No				No			No	No	Yes	48	10
S	Yes	10	Yes	TCZ			Yes	Meropenem		No	No	N/A	35	N/A
S	Yes	10	No				Yes	Gentamycine		No	No	N/A	64	N/A
S	Yes	10	No				Yes	Ceftriaxone		No	No	No	44	24
S	Yes	14	Yes	TCZ	Anti-IL-1	Plasma	Yes	Ceftriaxone	Meropenem	No	No	No	96	46
M	Yes	13	No				Yes	Ceftriaxone		No	Yes	No	84	28
S	Yes	12	Yes	TCZ			Yes	Ceftriaxone		No	No	No	45	36
S	Yes	11	Yes	TCZ	Anti-IL-1		Yes	Ceftriaxone		No	No	N/A	63	N/A
S	Yes	22	Yes	TCZ			No			No	No	No	180	N/A
S	Yes	10	Yes				No			No	Yes	Yes	106	16
S	Yes	13	Yes	İmmun plazma			Yes	Ceftriaxone	Meropenem	Yes	No	N/A	74	N/A
S	Yes	23	Yes	TCZ			Yes	Meronem		Yes	No	N/A	256	N/A
M	Yes	11	Yes	Anti-IL-1			Yes	Ceftriaxone		Yes	No	N/A	127	N/A
S	Yes	17	Yes	TCZ	ACT	Plasma	Yes	Ceftriaxone	Meropenem	Yes	No	N/A	345	N/A
S	Yes	14	Yes	TCZ	ACT		Yes	Ceftriaxone		Yes	No	N/A	156	N/A
S	Yes	17	No				Yes	Meronem		No	No	No	106	60
S	Yes	10	Yes	Anti-IL-1			Yes	Ceftriaxone		No		No	62	36
S	Yes	8	Yes	ACT			Yes	Ceftriaxone		No	No	Yes	24	4
S	Yes	24	Yes	Anti-IL-1			Yes	Ceftriaxone	Meropenem	No	No	No	124	76